Changing Patterns of Drug and Alcohol Use in Fatally Injured Drivers in Washington State

Abstract

We have previously reported on patterns of drug and alcohol use in fatally injured drivers in Washington State. Here we revisit that population to examine how drug use patterns have changed in the intervening 9 years. Blood and serum specimens from drivers who died within 4 h of a traffic accident between February 1, 2001, and January 31, 2002, were analyzed for illicit and therapeutic drugs and alcohol. Drugs when present were quantitated. Samples suitable for testing were obtained from 370 fatally injured drivers. Alcohol was detected above 0.01 g/100 mL in 41% of cases. The mean alcohol concentration for those cases was 0.17 g/100 mL (range 0.02-0.39 g/100 mL). Central nervous system (CNS) active drugs were detected in 144 (39%) cases. CNS depressants including carisoprodol, diazepam, hydrocodone, diphenhydramine, amitriptyline, and others were detected in 52 cases (14.1%), cannabinoids were detected in 47 cases (12.7%), CNS stimulants (cocaine and amphetamines) were detected in 36 cases (9.7%), and narcotic analgesics (excluding morphine which is often administered iatrogenically in trauma cases) were detected in 12 cases (3.2%). For those cases which tested positive for alcohol c. 40% had other drugs present which have the potential to cause or contribute to the driver's impairment. Our report also considers the blood drug concentrations in the context of their interpretability with respect to driving impairment. The data reveal that over the past decade, while alcohol use has declined, some drug use, notably methamphetamine, has increased significantly (from 1.89% to 4.86% of fatally injured drivers) between 1992 and 2002. Combined drug and alcohol use is a very significant pattern in this population and is probably overlooked in DUI enforcement programs.

Role of the Serotonergic System in Reduced Pulmonary Function after Exposure to Methamphetamine

“…Although it is difficult to draw comparisons between exposures in humans and mice, in our previous work exploring lung injury after exposure to 25 to 100 mg MA, the doses of MA causing lung injury resulted in plasma MA levels that were well below the mean MA plasma level of 730 ng/ml reported for MA users (21). However, it is likely that the findings in our initial study more closely modeled the respiratory effects expected to be seen in MA users rather than in environmental exposures.…”

Determination of Benzodiazepines in Oral Fluid Using LC-MS-MS

“…They are also used as muscle-relaxants and anti-convulsants. They are often detected in incidents of driving under the influence of drugs (DUID) and in combination with other medications (2,3). Oral fluid is becoming increasingly used as a specimen in many areas of forensic and clinical interest, including collection at the roadside during traffic stops.…”

The role of pharmacoepidemiological studies in the market withdrawal of carisoprodol (Somadril®) in Europe, 167-172

“…Three studies on apprehended drivers shed light on this adverse effect of carisoprodol. First, a case series by Logan and co-workers indicated that carisoprodol by itself could cause traffic related impairment with blood drug concentrations within the range observed with normal therapeutic use (36,37). Second, an analysis of secular trends from our group showed that drivers using carisoprodol were stopped by the police and that the number of drivers related closely to the amount of carisoprodol sold to the population (38).…”